Clinical Implications of Revised Pooled Cohort Equations for Estimating Atherosclerotic Cardiovascular Disease Risk
- PMID: 29868850
- DOI: 10.7326/M17-3011
Clinical Implications of Revised Pooled Cohort Equations for Estimating Atherosclerotic Cardiovascular Disease Risk
Abstract
Background: The 2013 pooled cohort equations (PCEs) are central in prevention guidelines for cardiovascular disease (CVD) but can misestimate CVD risk.
Objective: To improve the clinical accuracy of CVD risk prediction by revising the 2013 PCEs using newer data and statistical methods.
Design: Derivation and validation of risk equations.
Setting: Population-based.
Participants: 26 689 adults aged 40 to 79 years without prior CVD from 6 U.S. cohorts.
Measurements: Nonfatal myocardial infarction, death from coronary heart disease, or fatal or nonfatal stroke.
Results: The 2013 PCEs overestimated 10-year risk for atherosclerotic CVD by an average of 20% across risk groups. Misestimation of risk was particularly prominent among black adults, of whom 3.9 million (33% of eligible black persons) had extreme risk estimates (<70% or >250% those of white adults with otherwise-identical risk factor values). Updating these equations improved accuracy among all race and sex subgroups. Approximately 11.8 million U.S. adults previously labeled high-risk (10-year risk ≥7.5%) by the 2013 PCEs would be relabeled lower-risk by the updated equations.
Limitations: Updating the 2013 PCEs with data from modern cohorts reduced the number of persons considered to be at high risk. Clinicians and patients should consider the potential benefits and harms of reducing the number of persons recommended aspirin, blood pressure, or statin therapy. Our findings also indicate that risk equations will generally become outdated over time and require routine updating.
Conclusion: Revised PCEs can improve the accuracy of CVD risk estimates.
Primary funding source: National Institutes of Health.
Comment in
-
When Given a Lemon, Make Lemonade: Revising Cardiovascular Risk Prediction Scores.Ann Intern Med. 2018 Jul 3;169(1):56-57. doi: 10.7326/M18-1175. Epub 2018 Jun 5. Ann Intern Med. 2018. PMID: 29868856 No abstract available.
Publication types
MeSH terms
Grants and funding
- N01 HC095163/HC/NHLBI NIH HHS/United States
- HHSN268201300049C/HL/NHLBI NIH HHS/United States
- HHSN268201300046C/HL/NHLBI NIH HHS/United States
- N01 HC095168/HC/NHLBI NIH HHS/United States
- U54 MD010724/MD/NIMHD NIH HHS/United States
- K08 HL121056/HL/NHLBI NIH HHS/United States
- DP2 MD010478/MD/NIMHD NIH HHS/United States
- HHSN268201300047C/HL/NHLBI NIH HHS/United States
- N01 HC095162/HC/NHLBI NIH HHS/United States
- UL1 TR001420/TR/NCATS NIH HHS/United States
- N01 HC095165/HC/NHLBI NIH HHS/United States
- N01 HC095169/HC/NHLBI NIH HHS/United States
- I01 HX002014/HX/HSRD VA/United States
- N01 HC095159/HC/NHLBI NIH HHS/United States
- HHSN268201300048C/HL/NHLBI NIH HHS/United States
- N01 HC095161/HC/NHLBI NIH HHS/United States
- N01 HC095166/HC/NHLBI NIH HHS/United States
- IK2 HX001368/HX/HSRD VA/United States
- UL1 TR001079/TR/NCATS NIH HHS/United States
- P30 DK092926/DK/NIDDK NIH HHS/United States
- UL1 TR000040/TR/NCATS NIH HHS/United States
- HHSN268201300050C/HL/NHLBI NIH HHS/United States
- N01 HC095167/HC/NHLBI NIH HHS/United States
- N01 HC095164/HC/NHLBI NIH HHS/United States
- N01 HC095160/HC/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical